Pear Therapeutics's total assets for Q were $95.13M, a decrease of -20.55% from the previous quarter. PEAR total liabilities were $64.54M for the fiscal quarter, a -4.36% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.